The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial

被引:40
作者
Javadi, Leila [1 ]
Ghavami, Mostafa [2 ]
Khoshbaten, Manouchehr [3 ]
Safaiyan, Abdolrasoul [4 ]
Barzegari, Abolfazl [5 ]
Gargari, Bahram Pourghassem [6 ]
机构
[1] Tabriz Univ Med Sci, Nutr Res Ctr, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Fac Paramed, Tabriz, Iran
[3] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran
[4] Rd Traff Injury Res Ctr, Dept Biostat & Epidemiol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[6] Tabriz Univ Med Sci, Sch Nutr & Food Sci, Dept Biochem & Diet Therapy, Nutr Res Ctr, Tabriz, Iran
关键词
Probiotic; Prebiotic; Liver Function; Steatosis; NAFLD; GUT MICROBIOTA; INSULIN-RESISTANCE; OBESITY; STEATOHEPATITIS; AMINOTRANSFERASES; ENDOTOXEMIA; MECHANISM; DIAGNOSIS; NAFLD; MICE;
D O I
10.5812/ircmj.46017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Oral administration of pro-and prebiotics has recently been considered as an effective way for nonalcoholic fatty liver disease (NAFLD) recovery. Objectives: The current study aimed at evaluating the effect of supplementation with probiotics and/or prebiotics on liver function tests in patients with NAFLD. Methods: In this double blind, placebo-control clinical trial, 75 subjects with NAFLD were voluntarily recruited from May 2013 to March 2014, in Iran. Participants were randomly assigned to 1 of 4 groups using a block randomization procedure. Group 1 received probiotic capsules (Bifidobacterium longum (BL) and Lactobacillus acidophilus (LA): 2 x 10(7) CFU/day), group 2 received prebiotic inulin high performance (HP): 10 g/day, group 3 received probiotic and the prebiotic, and group 4 received a placebo for 3 months. The sample size was determined on the basis of a primary outcome of a change in aspartate aminotransferase (AST) level. Results: Anintergroup comparison indicated that the AST (P =0.006) and alanine aminotransferase (ALT) (P = 0.04) levels decreased at the end of the study. Aspartate Aminotransferase (mean difference of group1 versus placebo with P value of 0.001, group2 versus placebo with P value of 0.045, group3 versus placebo with P value of 0.015) and ALT (mean difference of group 1 versus placebo with P value of 0.009, group 2 versus placebo with P value of 0.041, and group 3 versus placebo with P value of 0.046) serum levels decreased significantly in all of the intervention groups compared to the placebo. The grade of fatty liver in group 1 (P of 0.027, and number needed to treat (NNT) = 3) and group 3 (P = 0.019 and NNT = 3) decreased compared to the placebo group with no significant changes in group 2. Conclusions: Supplementation with probiotics and/or prebiotics improved aminotransferase enzymes,and supplementation with probiotics or pro-and prebiotics recovered the grade of fatty liver in NAFLD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
    Mofidi, Fatemeh
    Poustchi, Hossein
    Yari, Zahra
    Nourinayyer, Babak
    Merat, Shahin
    Sharafkhah, Maryam
    Malekzadeh, Reza
    Hekmatdoost, Azita
    BRITISH JOURNAL OF NUTRITION, 2017, 117 (05) : 662 - 668
  • [42] Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy A Secondary Analysis of a Randomized Clinical Trial
    Kalinowski, Piotr
    Paluszkiewicz, Rafal
    Ziarkiewicz-Wroblewska, Bogna
    Wroblewski, Tadeusz
    Remiszewski, Piotr
    Grodzicki, Mariusz
    Krawczyk, Marek
    ANNALS OF SURGERY, 2017, 266 (05) : 738 - 745
  • [43] Occurrence and clinical management of nonalcoholic fatty liver disease in obesity patients: a literature review
    Cui, Han
    Zhang, XiuWei
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (05) : 579 - 584
  • [44] Effects of probiotic (Primalac 454) on nonalcoholic fatty liver disease in broilers
    Yalcin, S. S.
    Gucer, S.
    Yalcin, S.
    Onbasilar, I.
    Kale, G.
    Coskun, T.
    REVUE DE MEDECINE VETERINAIRE, 2011, 162 (07) : 371 - 376
  • [45] Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
    Eckard, Carly
    Cole, Renee
    Lockwood, Joshua
    Torres, Dawn M.
    Williams, Christopher D.
    Shaw, Janet C.
    Harrison, Stephen A.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2013, 6 (04) : 249 - 259
  • [46] Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
    Xue, Lanfeng
    Deng, Zhiliang
    Luo, Wenhui
    He, Xingxiang
    Chen, Yu
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [47] A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia
    Valenti, Luca
    Fracanzani, Anna Ludovica
    Dongiovanni, Paola
    Rovida, Serena
    Rametta, Raffaela
    Fatta, Erika
    Pulixi, Edoardo Alessandro
    Maggioni, Marco
    Fargion, Silvia
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (11) : 3002 - 3010
  • [48] Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety
    Gianturco, Vincenzo
    Troisi, Giovanni
    Bellomo, Alessia
    Bernardini, Sciaila
    D'Ottavio, Elisa
    Formosa, Valeria
    Lo Iacono, Cristina
    Verrusio, Walter
    Marigliano, Benedetta
    Marigliano, Vincenzo
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 570 - 576
  • [49] The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease
    Malik, Raza
    Chang, Michael
    Bhaskar, Killimangalam
    Nasser, Imad
    Curry, Michael
    Schuppan, Detlef
    Byrnes, Valerie
    Afdhal, Nezam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (04) : 564 - 568
  • [50] The therapeutic effects of chicory seed aqueous extract on cardio-metabolic profile and liver enzymes in nonalcoholic fatty liver disease; a double blind randomized clinical trial
    Marzban, Maral
    Bahrami, Mohsen
    Kamalinejad, Mohammad
    Tahamtan, Maryam
    Khavasi, Narjes
    Monfared, Mahdie Haji
    Jameshorani, Maryam
    IMMUNOPATHOLOGIA PERSA, 2024, 10 (02):